Altimmune is redefining success in both obesity and MASH to position Pemvidutide in blue ocean categories. Read why I rate ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

Structure Therapeutics, Inc. Sponsored ADR ( (GPCR) ) has provided an announcement.

A previously unknown population of neurons in the hypothalamus may pave the way for new obesity treatments. Obesity impacts a ...

Regardless of the type or combination of obesity treatment, goal setting is an important part of any obesity treatment plan. Someone may want to lose a large amount of weight. But it's important to ...

The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, ...

“We know obesity is a state of systemic inflammation, resulting from complex biochemical pathway, rather than simply excess ...

Glucagon-like peptide-1 (GLP-1) type obesity drug craze is hot.Demand for Novo Nordisk's Ozempic, Hugo Bee, and Eli Lilly's ...

Merck on Wednesday signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech's ...

David Ricks told a lunch audience at the Economic Club of Washington, D.C., that Zepbound could quickly become the most ...

“These findings add a critical new component to our understanding of how neurons impact appetite and obesity,” Dr Herb said. “This could be a future target for obesity treatment, such as by activating ...